Improving Diabetic Retinopathy Outcomes: FIELD Fenofibrate
Kalra, S.; Sahay, R.
Journal of the Association of Physicians of India 66(12): 55-57
2018
ISSN/ISBN: 0004-5772 PMID: 31313550 Document Number: 695273
This brief communication describes evidence which proves the beneficial effects of fenofibrate on the retinal vasculature in type 2 diabetes, acting via both lipid lowering and non-lipid lowering mechanisms. It discusses data from FIELD and other trials to support the use of fenofibrate as a secondary preventive therapy for diabetic retinopathy. These data contrast with the lack of retinal benefit shown in major cardiovascular outcome trials of other blood pressure lowering and glucose lowering agents such as empagliflozin, liraglutide, perindopril + indapamide, and ramipril.